Term ends Oct 14, 2036 · High confidence
20-year base term ends Oct 14, 2036
Held by Immedica Pharma US Inc.
Filed Oct 14, 2016 as application 15/294,135 · Granted Sep 22, 2020
Base term, 20 years from filing
Today
2016
2036
Clock starts
Oct 14, 2016
Oct 14, 2016
Term ends
Oct 14, 2036
Oct 14, 2036
Granted
Sep 22, 2020
Sep 22, 2020
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 14, 2016, when this application, 15/294,135, was filed | Oct 14, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 14, 2036 | High confidence |
This family
| US 10,780,099 | this patent Oct 2036 | Oct 2036 |
| Application 16/992,873 | Abandoned not computed | not computed |
| Application 17/854,437 | Abandoned not computed | not computed |
| Application 18/167,261 | Abandoned not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 16, 2016 Reel 40340, frame 312 | Zhang, Mingbao; Glowaky, Raymond C.; Czekai, David | Marinus Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| May 11, 2021 Reel 56206, frame 266 | Marinus Pharmaceuticals, Inc. | Oaktree Fund Administration, LLC | Security Interest |
| Oct 28, 2022 Reel 61580, frame 171 | Marinus Pharmaceuticals, Inc. | Sagard Healthcare Royalty Partners, LP | Security Interest |
| Feb 13, 2025 Reel 70204, frame 35 | Sagard Healthcare Partners Funding Company SPE 1, LLC | Marinus Pharmaceuticals, Inc. | Release of Security Interest |
| Feb 20, 2025 Reel 70278, frame 496 | Oaktree Fund Administration, LLC | Marinus Pharmaceuticals, Inc. | Release of Security Interest |
| May 14, 2025 Reel 71116, frame 191 | Marinus Pharmaceuticals, Inc. | Immedica Pharma US Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2036
Term ends Oct 14, 2036. Maintenance fees still fall due before then
Citations
10
later US patents cite this one
That is top 25% of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.